Monday , 24 February 2025
0

No products in the cart.

Worldwide News Worldwide News
0

No products in the cart.

Home Health Seaport Therapeutics Secures $225M for New Kind of Depression Drug
Health

Seaport Therapeutics Secures $225M for New Kind of Depression Drug

October 27, 20241 Mins read38 Views
Seaport Therapeutics Secures $225M for New Kind of Depression Drug

Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more.

The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.

Previous post

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Health

Healthcare AI is developing at a rapid rate, and the industry’s attitude...

ByFebruary 24, 2025

A paper by Proudman et al. (2024) finds that doing so would...

ByFebruary 22, 2025
Health

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird...

ByFebruary 21, 2025
Health

Hospitals are adopting AI technology more than ever before, but they still...

ByFebruary 21, 2025

Abous us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis

Subscribe Now

    Subscribe to our mailing list to receives daily updates direct to your inbox!
    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com